Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Condition(s):Stage IV Melanoma; Stage III Melanoma; Advanced MelanomaLast Updated:October 19, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Stage IV Melanoma; Stage III Melanoma; Advanced MelanomaLast Updated:October 19, 2023Active, not recruiting
Condition(s):Effect of DrugLast Updated:February 21, 2023Recruiting
Condition(s):Adenoid Cystic CarcinomaLast Updated:January 23, 2023Completed
Condition(s):Acne VulgarisLast Updated:October 7, 2011Unknown status
Condition(s):Neuroblastoma; Neuroendocrine TumorLast Updated:June 21, 2016Withdrawn
Condition(s):Solid TumorLast Updated:November 29, 2023Recruiting
Condition(s):MelanomaLast Updated:September 21, 2023Completed
Condition(s):Photodamaged Skin; PhotoagingLast Updated:April 2, 2021Unknown status
Condition(s):Acne VulgarisLast Updated:April 1, 2021Completed
Condition(s):Myelodysplastic SyndromesLast Updated:September 1, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.